🎯 check BMS-986165 (Deucravacitinib) product page
BMS-986165 (Deucravacitinib) is a potent, highly selective, allosteric TYK2 inhibitor. It affects IL-12, IL-23, and type I interferon signaling by binding to the TYK2 pseudokinase domain (JH2) to block STAT phosphorylation, effectively inhibiting inflammatory responses and abnormal cell proliferation.